Fenofibric AcidDelayed-Release (Par Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the Fenofibric Acid drug offered from Par Pharmaceutical, Inc.. This Peroxisome Proliferator Receptor alpha Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Par Pharmaceutical, Inc. |
NON-PROPRIETARY NAME: | Fenofibric Acid |
SUBSTANCE NAME: | CHOLINE FENOFIBRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Peroxisome Proliferator Receptor alpha Agonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, DELAYED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2013-07-18 |
END MARKETING DATE: | 0000-00-00 |
Fenofibric Acid Delayed-Release HUMAN PRESCRIPTION DRUG Details:
Item Description | Fenofibric Acid Delayed-Release from Par Pharmaceutical, Inc. |
LABELER NAME: | Par Pharmaceutical, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 45(mg/1) |
START MARKETING DATE: | 2013-07-18 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 10370-209_c67613ea-a237-4e5b-bb68-b511d023d1da |
PRODUCT NDC: | 10370-209 |
APPLICATION NUMBER: | ANDA201573 |
Other CHOLINE FENOFIBRATE Pharmaceutical Manufacturers / Labelers: